The ASCO Post Editorial Board

Editor-in-Chief

    JAMES O. ARMITAGE, MD, University of Nebraska Medical Center

Deputy Editor

    ELIZABETH C. REED, MD, University of Nebraska Medical Center

Associate Editors

    JAME ABRAHAM, MD, Cleveland Clinic

    SYED A. ABUTALIB, MD, Cancer Treatment Centers of America

    MANMEET SINGH AHLUWALIA, MD, PhD, Cleveland Clinic

    CHANDRAKANTH ARE, MD, University of Nebraska Medical Center

    JOSEPH S. BAILES, MD, Texas Oncology

    LAURENCE H. BAKER, DO, University of Michigan Health System

    RICHARD R. BARAKAT, MD, Memorial Sloan Kettering Cancer Center

    CHARLES L. BENNETT, MD, PhD, MPP, University of South Carolina, Columbia

    DOUGLAS W. BLAYNEY, MD, Stanford University Medical Center

    PHILIP D. BONOMI, MD, Rush University Medical Center

    RICHARD BOXER, MD, University of Wisconsin School of Public Health and Medicine, David Geffen School of Medicine at UCLA

    HAROLD J. BURSTEIN, MD, Dana-Farber Cancer Institute

    ROBERT W. CARLSON, MD, National Comprehensive Cancer Network

    BARRIE CASSILETH, PhD, Los Angeles

    JAY S. COOPER, MD, Maimonides Medical Center

    JOHN COX, DO, Texas Oncology

    E. DAVID CRAWFORD, MD, University of Colorado

    NANCY E. DAVIDSON, MD, Fred Hutch/University of Washington

    GEORGE D. DEMETRI, MD, Dana-Farber Cancer Institute

    STEPHEN B. EDGE, MD, Roswell Park Cancer Institute

    PAUL F. ENGSTROM, MD, Fox Chase Cancer Center

    DAVID S. ETTINGER, MD, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    BISHOY MORRIS FALTAS, MD, Weill Cornell Medical College

    JOHN A. FRACCHIA , MD, New York Urological Associates

    ALISON FREIFELD, MD, University of Nebraska Medical Center

    LOUIS B. HARRISON, MD, Moffitt Cancer Center

    BRANDON M. HAYES-LATTIN, MD, Oregon Health & Science University, Portland

    JIMMIE HOLLAND, MD, Memorial Sloan Kettering Cancer Center

    CLIFFORD A. HUDIS, MD, FACP, Memorial Sloan Kettering Cancer Center

    NORA JANJAN, MD, MPSA, MBA, National Center for Policy Analysis

    HAGOP M. KANTARJIAN, MD, MD Anderson Cancer Center

    MARIO LACOUTURE, MD, Memorial Sloan Kettering Cancer Center

    THEODORE S. LAWRENCE, MD, PhD, University of Michigan Comprehensive Cancer Center

    STEPHEN J. LEMON, MD, MPH, Overlake Medical Center

    ALLEN S. LICHTER, MD, Ann Arbor, Michigan

    STUART LICHTMAN, MD, Memorial Sloan Kettering Cancer Center–Commack, New York

    MICHAEL P. LINK, MD, Stanford University Medical Center

    JOHN L. MARSHALL, MD, Ruesch Center for the Cure of GI Cancer at Georgetown University

    MARY S. MCCABE, RN, MA, Memorial Sloan Kettering Cancer Center

    WILLIAM T. MCGIVNEY, PhD, McGivney Global Advisors

    JAMES L. MULSHINE, MD, Rush University Medical Center

    DAVID PFISTER, MD, Memorial Sloan Kettering Cancer Center

    DEREK RAGHAVAN, MD, PhD, Levine Cancer Institute, Carolinas HealthCare System

    STEVEN T. ROSEN, MD, City of Hope National Medical Center

    LEE S. SCHWARTZBERG, MD, University of Tennessee Health Science Center

    ANDREW D. SEIDMAN, MD, Memorial Sloan Kettering Cancer Center

    SAMUEL SILVER, MD, PhD, University of Michigan Health System

    GEORGE W. SLEDGE, MD, Stanford University School of Medicine

    THOMAS J. SMITH, MD, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    JAMIE H. VON ROENN, MD, American Society of Clinical Oncology

    LYNN D. WILSON, MD, Yale University School of Medicine

    STANLEY WINOKUR, MD, Singer Island, Florida

    WILLIAM C. WOOD, MD, Winship Cancer Institute, Emory University

International Editors

    CLEMENT ADEBAMOWO, BM, ChB (Hons), ScD, University of Ibadan, Nigeria

    EDUARDO CAZAP, MD, PhD, International Union Against Cancer (UICC), Buenos Aires, Argentina

    RAKESH CHOPRA, MD, Artemis Healthsciences Institute, Gurgaon, Haryana, India

    NAGI EL-SAGHIR, MD, American University of Beirut, Lebanon

    MARY GOSPODAROWICZ, MD, Princess Margaret Hospital, Toronto, Ontario, Canada

    JACEK JASSEM, MD, Medical University of Gdansk, Poland

    DAVID KHAYAT, MD, Pitie-Salpetriere Hospital, Paris, France

    TONY MOK, MD, The Chinese University of Hong Kong, Shatin, Hong Kong

    ELIEZER ROBINSON, MD, National Council for Oncology, Israeli Cancer Association, Haifa, Israel

    NAGAHIRO SAIJO, MD, PhD, Kinki University School of Medicine, Osaka, Japan

    JOHN F. SMYTH, MD, University of Edinburgh, Edinburgh, Scotland

    DANIEL A. VOROBIOF, MD, Sandton Oncology Centre, Johannesburg, South Africa

The Editors' conflict of interest disclosure information is available here.

Advertisement

Advertisement



Advertisement